← Back 
FOLD
Amicus Therapeutics · Biotech · ~$5B
$14.42 -0.01
(-0.07%)
STRONG BUY 82
Live quote as of
Hold Period
Long-Term
Hot Streak
🔥 Hot (3d)
Position Size
3%
Earnings
May 8 (46d)
Sector RS
Outperformer
Why We Like It
Rare disease biotech. 17% revenue growth, earnings +87% next year.
Investment Strategy
Long-Term
Core biotech position at <$10 entry.
Recommended allocation: 3% — Small / speculative
Confidence Breakdown
Fundamentals (35%) 82
Technicals (25%) 80
Sentiment (20%) 78
Catalysts (15%) 85
Risk Adjusted (5%) 80
Overall Score 82
Bull Case
Proven drug on market. 61% analyst upside.
Bear Case
Regulatory risk. Rare disease concentration.
Analyst Consensus
14 analysts covering this stock · Period: 2026-03-01
2
4
8
Strong Buy: 2 Buy: 4 Hold: 8 Sell: 0 Strong Sell: 0
About Amicus Therapeutics Inc
Log in to continue
Create a free account to access the full RichSense intelligence dashboard.
Log In Don't have an account? Subscribe free